Clinical Trial Detail

NCT ID NCT03260491
Title U3-1402 in Metastatic or Unresectable Non-Small Cell Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Daiichi Sankyo, Inc.
Indications

lung non-small cell carcinoma

Therapies

U3-1402

Age Groups: adult senior

No variant requirements are available.